187 related articles for article (PubMed ID: 10880412)
21. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation.
Schächinger V; Britten MB; Elsner M; Walter DH; Scharrer I; Zeiher AM
Circulation; 1999 Oct; 100(14):1502-8. PubMed ID: 10510052
[TBL] [Abstract][Full Text] [Related]
22. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study).
Anderson TJ; Elstein E; Haber H; Charbonneau F
J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260
[TBL] [Abstract][Full Text] [Related]
23. The relationship between slow coronary flow and angiotensin converting enzyme and ATIIR1 gene polymorphisms.
Yalcin AA; Kalay N; Caglayan AO; Kayaalti F; Duran M; Ozdogru I; Inanc MT; Dogan A; Basar E; Oguzhan A
J Natl Med Assoc; 2009 Jan; 101(1):40-5. PubMed ID: 19245071
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
[TBL] [Abstract][Full Text] [Related]
25. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.
O'Driscoll G; Green D; Rankin J; Stanton K; Taylor R
J Clin Invest; 1997 Aug; 100(3):678-84. PubMed ID: 9239416
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients.
Perticone F; Ceravolo R; Maio R; Ventura G; Zingone A; Perrotti N; Mattioli PL
Hypertension; 1998 Apr; 31(4):900-5. PubMed ID: 9535412
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
Hornig B; Arakawa N; Haussmann D; Drexler H
Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
[TBL] [Abstract][Full Text] [Related]
28. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.
Nakai K; Itoh C; Miura Y; Hotta K; Musha T; Itoh T; Miyakawa T; Iwasaki R; Hiramori K
Circulation; 1994 Nov; 90(5):2199-202. PubMed ID: 7955173
[TBL] [Abstract][Full Text] [Related]
29. The ACE-DD genotype is associated with endothelial dysfunction in postmenopausal women.
Méthot J; Hamelin BA; Arsenault M; Bogaty P; Plante S; Poirier P
Menopause; 2006; 13(6):959-66. PubMed ID: 17003740
[TBL] [Abstract][Full Text] [Related]
30. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
31. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
[TBL] [Abstract][Full Text] [Related]
32. Polymorphic inhibition of human angiotensin I-converting enzyme by enalaprilat.
Lee EJ
Eur J Clin Pharmacol; 1995; 49(3):173-5. PubMed ID: 8665992
[TBL] [Abstract][Full Text] [Related]
33. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
[TBL] [Abstract][Full Text] [Related]
34. Relation between the insertion/deletion polymorphism of the angiotensin I converting enzyme gene and restenosis after coronary stenting.
Gürlek A; Güleç S; Karabulut H; Bokesoy I; Tutar E; Pamir G; Alpman A; Toydemir R; Aras O; Oral D
J Cardiovasc Risk; 2000 Dec; 7(6):403-7. PubMed ID: 11155292
[TBL] [Abstract][Full Text] [Related]
35. ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension.
Dell'omo G; Penno G; Pucci L; Lucchesi D; Fotino C; Del Prato S; Pedrinelli R
Clin Sci (Lond); 2006 Dec; 111(6):357-64. PubMed ID: 16889537
[TBL] [Abstract][Full Text] [Related]
36. Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion/deletion polymorphism of the ACE gene.
Niemiec P; Zak I; Wita K
Genet Test; 2007; 11(4):353-9. PubMed ID: 18294050
[TBL] [Abstract][Full Text] [Related]
37. Deletion polymorphism of the angiotensin I-converting enzyme gene in elderly patients with coronary heart disease.
Marković BB; Bergovec M; Reiner Z; Sertić J; Vincelj J; Marković M
Coll Antropol; 2007 Mar; 31(1):179-83. PubMed ID: 17598398
[TBL] [Abstract][Full Text] [Related]
38. Lack of association of angiotensin converting enzyme gene polymorphism or serum enzyme activity with coronary artery disease in Japanese subjects.
Fujimura T; Yokota M; Kato S; Hirayama H; Tsunekawa A; Inagaki H; Takatsu F; Nakashima N; Yamada Y
Am J Hypertens; 1997 Dec; 10(12 Pt 1):1384-90. PubMed ID: 9443774
[TBL] [Abstract][Full Text] [Related]
39. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
Zeiher AM; Schächinger V
Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
[TBL] [Abstract][Full Text] [Related]
40. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
